在癌症患者中探索外流.
Tuan D Pham1, Taichiro Tsunoyama2
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AD, UK.
Cancers
|July 13, 2024
概括
癌症治疗期间输液药物的泄漏,需要更好的预防和管理. 本文重点介绍了人工智能和智能导管等新技术,以提高患者的安全性和治疗结果.
科学领域:
- 在瘤学瘤学.
- 患者安全 患者安全
- 医疗技术 医疗技术 医学技术
背景情况:
- 静脉外流,即静脉注射物质的意外泄漏,是癌症治疗中的一个重大并发症.
- 它在化疗和放射治疗期间带来了挑战,影响了患者的安全性和治疗疗效.
研究的目的:
- 在癌症患者中全面审查扩散,涵盖病理生理学,危险因素,诊断,管理和长期影响.
- 识别知识缺口,并提出未来的研究方向,以预防和管理扩散.
- 突出新兴技术,可以改善外置护理.
主要方法:
- 关于病理生理学,发病率,风险因素,临床表现,诊断,预防,管理,并发症和长期影响的综合文献综述.
- 探索目前和新兴的技术,以预防和管理扩散.
- 确定研究缺口和未来方向.
主要成果:
- 扩散在癌症治疗中带来了各种各样的挑战,需要强有力的预防和管理策略.
- 新兴技术,包括先进的静脉可视化,智能导管,向药物输送,新的局部治疗和基于人工智能的图像分析,显示出希望.
- 持续的研究对于完善预防和管理方案至关重要.
结论:
- 本综述为医疗保健专业人员提供了洞察力,以提高患者的安全性和优化临床实践与extravasation有关.
- 它强调了持续研究和创新的重要性,以改善癌症患者经历外流事件的治疗结果.
- 采用新技术是减轻外流风险和改善患者护理的关键.
更多相关视频
09:42Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis
Published on: June 26, 2019
8.8K
08:24Extended Time-lapse Intravital Imaging of Real-time Multicellular Dynamics in the Tumor Microenvironment
Published on: June 12, 2016
8.2K
相关概念视频
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
